-
Recent Posts
Recent Comments
Patrick J. Halloran,… on Shire Development, LLC et al.… Kevin E Noonan on Shire Development, LLC et al.… Qualities of a Good… on Edwards Life Sciences AG et al… Archives
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- July 2011
- February 2011
- January 2011
Categories
- America Invents Act
- Analgous Art
- Anticipation (35 USC 102)
- Antitrust
- Appeal
- Arbitration
- Article III disputes
- Assignment / Ownership
- Attorney's Fees
- Best mode
- Biosimilars
- Business methods
- Certificate of Correction
- Claim
- Claim Construction
- Claim Differentiation
- Claim Preclusion
- Claim Vitiation
- Collateral estoppel
- Conception and Reduction to Practice
- Contributory Infringement
- Covered Business Method Reviews
- Damages
- Derivation of Invention
- Design Patents
- Diligence
- Disclaimers
- Discovery
- Doctrine of equivalents
- Double Patenting
- Enablement
- Equitable estoppel
- Expert Testimony
- False Marking
- Functional limitations
- Generics / ANDA
- Importation
- Indefiniteness
- Inducement to Infringe
- Inequitable Conduct
- Infringement
- Inherency
- Injunction
- Inter Parties Review (IPR)
- Interference
- International Trade Commission
- Inventorship
- IPR
- Issue Preclusion
- Jurisdiction
- Laches
- Licensing
- Lost Profits
- Malpractice
- Means-plus-function
- Method claims
- Negative Limitations
- Obviousness
- Obviousness-Teaching Away
- On-Sale Bar
- Patent Exhaustion
- Patent Marking
- Patent Prosecution
- Patent Term Extension
- Patentability
- Post-grant review
- Preamble
- Priority
- Privilege
- Procedural Issues
- Prosecution History Estoppel
- Public Use
- Reexamination
- Reissue
- Royalties
- Software
- Summary Judgment
- Trade Dress
- Trade Secret
- Trademarks
- U.S. Supreme Court
- Uncategorized
- Unjust enrichment
- Venue
- Willfullness
- Written description
Meta
- America Invents Act Anticipation (35 USC 102) Appeal Assignment / Ownership Attorney's Fees Claim Construction Claim Differentiation Collateral estoppel Damages Doctrine of equivalents Expert Testimony Generics / ANDA Indefiniteness Inducement to Infringe Inequitable Conduct Infringement Injunction Inter Parties Review (IPR) Inventorship IPR Means-plus-function Obviousness Patentability Preamble Prosecution History Estoppel Reexamination Trademarks Uncategorized Willfullness Written description
Category Archives: Prosecution History Estoppel
Aylus Networks, Inc. v. Apple Inc.
Docket No. 2016-1599 MOORE, LINN, STOLL May 11, 2017 Brief Summary: DC grant of SJ on non-infringement to Apple affirmed since “statements made by a patent owner during an IPR proceeding can be relied on to support a finding of … Continue reading
TMC Fuel Injection System, LLC v. Ford Motor Company
Docket No. 2016-2122 PROST, WALLACH, STOLL March 27, 2017 Non-precedential Brief Summary: DC grant of SJ of noninfringement of US 7,318,414 relating to fuel injection systems to Ford on the basis of prosecution history disclaimer (PHD) affirmed (“even if there … Continue reading
In Re: Lawrence B. Lockwood
Docket No. 2016-1371 PROST, MOORE, CHEN February 13, 2017 Non-precedential Brief Summary: Board claim construction and finding of anticipation affirmed. Summary: Lockwood appealed Board affirmance following ex parte reexamination requested by an anonymous third party of the examiner’s determination that … Continue reading
Roxane Laboratories, Inc. v. Camber Pharmaceuticals, Inc. et al.
Docket No. 2016-1028 LOURIE, MAYER, O’MALLEY November 17, 2016 Non-precedential Brief Summary: DC claim construction regarding the claimed capsule size and decision to transfer affirmed. Summary: Roxane appealed from a stipulated judgment of noninfringement of its US 8,563,032 relating to … Continue reading
Profoot, Inc. v. Merck & Co., Inc.
Docket No. 2016-1216 PROST, TARANTO, HUGHES October 26, 2016 Non-precedential Brief Summary: DC construction and judgment based on claim construction affirmed basred in part on prosecution history of parental patent. Summary: ProFoot appealed DC stipulated judgment of noninfringement following claim … Continue reading
Poly-America, L.P. v. API Industries, Inc.
Docket No. 2016-1200 PROST, REYNA, HUGHES October 14, 2016 Brief Summary: DC claim construction based on “clear and unequivocal statements” in the specification and during prosecution affirmed. Summary: Poly-America appealed DC claim construction of the term “short seal” in US … Continue reading
MIT, et al. v. Shire Pharmaceuticals, Inc. et al.
Docket No. 2015-1881 O’MALLEY, CHEN, STOLL October 13, 2016 Brief Summary: DC decision of infringement and no invalidity based on finding of no prosecution history estoppel or indefiniteness affirmed. Summary: MIT appealed DC claim construction after the parties stipulated to … Continue reading
